Brain-derived neurotrophic factor

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Brain-derived neurotrophic factor or BDNF is a protein in the neurotrophic family.[1] The name BDNF is also used to refer to the related gene that expresses BDNF.[1]

Function[edit | edit source]

ME/CFS[edit | edit source]

Notable studies[edit | edit source]

  • 2015, Brain-derived neurotrophic factor concentration may not be depressed in chronic fatigue syndrome[2] - (Abstract)
  • 2015, Exercise and caffeine improve sustained attention following fatigue independent of fitness status[3] - (Full text)
  • 2015, Brain-derived neurotrophic factor (BDNF) as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?[4] - (Full text)
  • 2020, DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia[5] - (Abstract)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 Binder, Devin K.; Scharfman, Helen E. (September 2004). "Brain-derived Neurotrophic Factor". Growth factors (Chur, Switzerland). 22 (3): 123–131. doi:10.1080/08977190410001723308. ISSN 0897-7194. PMC 2504526. PMID 15518235.
  2. Patrick, David M.; Miller, Ruth R.; Steiner, Theodore; Gardy, Jennifer L.; Parker, Shoshana M.; Tang, Patrick (April 3, 2015). "Brain-derived neurotrophic factor concentration may not be depressed in chronic fatigue syndrome". Fatigue: Biomedicine, Health & Behavior. 3 (2): 122–125. doi:10.1080/21641846.2015.1024004. ISSN 2164-1846.
  3. Kumar, Namrita; Wheaton, Lewis A.; Snow, Teresa K.; Millard-Stafford, Melinda (April 3, 2015). "Exercise and caffeine improve sustained attention following fatigue independent of fitness status". Fatigue: Biomedicine, Health & Behavior. 3 (2): 104–121. doi:10.1080/21641846.2015.1027553. ISSN 2164-1846.
  4. Nijs, Jo; Meeus, Mira; Versijpt, Jan; Moens, Maarten; Bos, Inge; Knaepen, Kristel; Meeusen, Romain (April 2015). "Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?". Expert Opinion on Therapeutic Targets. 19 (4): 565–576. doi:10.1517/14728222.2014.994506. ISSN 1744-7631. PMID 25519921.
  5. Polli, Andrea; Ghosh, Manosij; Bakusic, Jelena; Ickmans, Kelly; Monteyne, Dora; Velkeniers, Brigitte; Bekaert, Bram; Godderis, Lode; Nijs, Jo (November 2020). "DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia". Arthritis & Rheumatology (Hoboken, N.J.). 72 (11): 1936–1944. doi:10.1002/art.41405. ISSN 2326-5205. PMID 32562379.